Gene patent ruling could improve access, patient care

06/13/2013 | CBS News · Medscape (free registration) · HealthDay News

The Supreme Court's decision Thursday to prohibit the patenting of human genes could improve patient care, boost access to genetic testing and cut costs, supporters say. The cost of gene testing will fall and access to second opinions will increase, according to the American Society for Clinical Pathology, one of the plaintiffs in the case. "Because of this ruling, patients will have greater access to genetic testing and scientists can engage in research on these genes without fear of being sued," said Dr. Myra F. Barginear, a New York oncologist.

View Full Article in:

CBS News · Medscape (free registration) · HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC